#United States #Minneapolis #LTR Pharma #Roxus ED #Vardenafil

Exciting Launch: Roxus® ED Nasal Spray Now in the U.S.

In a significant development for men's health, LTR Pharma Limited, an Australian pharmaceutical firm, has just announced that Roxus®, an innovative nasal spray treatment for erectile dysfunction (ED), is now available to men across the United States. This groundbreaking medication delivers vardenafil, an active ingredient also found in the well-known pill treatment Viagra®, but through an advanced intranasal delivery system that substantially reduces the time needed to achieve peak blood levels.

How Roxus® Works

Traditional methods of treating ED involve taking pills, which can often take 45 to 60 minutes to take effect, leading to inconvenient wait times and worries about food consumption interfering with absorption. However, what sets Roxus apart is its intranasal formulation. In clinical studies, this spray has shown to reach peak levels in the bloodstream in a remarkable median time of just 10 minutes — a considerable improvement over conventional tablets.

This means that men can experience the effects of Roxus substantially faster, often within 5 to 10 minutes, allowing for greater spontaneity and satisfaction for both partners. Furthermore, the nasal spray is effective at only one-quarter of the tablet dose, making it a highly efficient option for those seeking treatment.

Clinical Perspective

Lee Rodne, Executive Chairman of LTR Pharma, emphasized the transformative nature of Roxus: "For twenty years, ED treatment has meant taking a pill, waiting an hour, and hoping dinner doesn't get in the way. Roxus changes that experience significantly." This sentiment is echoed by Dr. Amy Pearlman, a noted urologist and member of LTR Pharma’s Scientific Advisory Board, who stated, "In sexual medicine, convenience is clinical. Roxus offers a unique chance to rethink the delivery of established treatments to improve patient experience and discretion."

How to Obtain Roxus®

Men interested in using Roxus can obtain a prescription through Mavrox, a telemedicine platform operated by Shed, allowing users to access men’s health services from the comfort of their own homes. The process is simple: users fill out an online health assessment on Mavrox.com/Roxus, where a licensed U.S. provider will review the information. If deemed appropriate for the user’s needs, prescriptions are dispensed by Strive Pharmacy and delivered discreetly to their doorsteps.

For those who prefer a more traditional route, consulting with a healthcare provider in-person is also an option. The versatility in prescription methods ensures that all patients have the opportunity to benefit from this innovative treatment. For further details, prospective users can visit Roxus.com.

Important Considerations

While Roxus presents an exciting solution, potential users must be aware of safety information. It is not recommended for individuals taking nitrates for chest pain or certain other medications, and it is essential to disclose any underlying heart, liver, or kidney issues to the prescribing physician. Users should also be mindful of potential side effects including headaches, nasal discomfort, and transient flushing.

Roxus is not FDA-approved as it is a compounded medication tailored to individual patient requirements based on valid prescriptions. Therefore, discussing personal health needs with a professional is crucial to ensuring that Roxus is the right fit.

About LTR Pharma

LTR Pharma Limited, listed on the ASX under the ticker LTP, is focused on developing rapid-action intranasal medications utilizing proprietary technology. With Roxus® leading the charge in the U.S. market, they hope to redefine ED treatments and improve the lives of many. Roxus is also progressing towards FDA review through its other product, SPONTAN®, available in Australia.

This launch not only brings promising changes to ED treatment but also signifies a shift towards more patient-centered healthcare solutions in men’s sexual health.